These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18685887)

  • 1. A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects.
    Kane MA
    Aesthetic Plast Surg; 2008 Nov; 32(6):933-5. PubMed ID: 18685887
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects: what if sample size and statistical tests mattered?
    Mangano A; Albertin A; La Colla L
    Aesthetic Plast Surg; 2009 Sep; 33(5):788. PubMed ID: 19543939
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects.
    Harii K; Kawashima M
    Aesthetic Plast Surg; 2008 Sep; 32(5):724-30. PubMed ID: 18663516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OnabotulinumtoxinA (Botox) in the Treatment of Crow's Feet Lines in Japanese Subjects.
    Harii K; Kawashima M; Furuyama N; Lei X; Hopfinger R; Lee E
    Aesthetic Plast Surg; 2017 Oct; 41(5):1186-1197. PubMed ID: 28733805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians.
    Choi SY; Koh YG; Lee YW; Son HS; Yoon YN; Kim G; Won C; Cho H; Son JS; Kim EK; Kim BJ
    J Dermatolog Treat; 2024 Dec; 35(1):2359511. PubMed ID: 38880494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of Skin Mechanical Properties in Patients Undergoing Botulinum Toxin Type A Injections of Forehead Rhytides.
    Min P; Zhang Z; Grassetti L; Perdanasari AT; Torresetti M; Pu Z; Zhang Y; Han S; Marsili R; Zhang YX; di Benedetto G; Lazzeri D
    Aesthetic Plast Surg; 2016 Jun; 40(3):410-20. PubMed ID: 26944891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females.
    Carruthers A; Carruthers J; Said S
    Dermatol Surg; 2005 Apr; 31(4):414-22; discussion 422. PubMed ID: 15871316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies.
    Beer KR; Shamban AT; Avelar RL; Gross JE; Jonker A
    Dermatol Surg; 2019 Nov; 45(11):1381-1393. PubMed ID: 30893162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.
    Kim JE; Song EJ; Choi GS; Lew BL; Sim WY; Kang H
    Plast Reconstr Surg; 2015 Mar; 135(3):732-741. PubMed ID: 25719692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.
    Sattler G; Callander MJ; Grablowitz D; Walker T; Bee EK; Rzany B; Flynn TC; Carruthers A
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2146-54. PubMed ID: 21134045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids.
    Carruthers A; Carruthers J
    Dermatol Surg; 2005 Oct; 31(10):1297-303. PubMed ID: 16188182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.
    Brandt F; Swanson N; Baumann L; Huber B
    Dermatol Surg; 2009 Dec; 35(12):1893-901. PubMed ID: 19549186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OnabotulinumtoxinA treatment of mild glabellar lines in repose.
    Carruthers A; Carruthers J; Lei X; Pogoda JM; Eadie N; Brin MF
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2168-71. PubMed ID: 21134048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study on glabellar wrinkle patterns in Indians.
    Kamat A; Quadros T
    Indian J Dermatol Venereol Leprol; 2019; 85(2):182-189. PubMed ID: 29620040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2).
    Carruthers JD; Fagien S; Joseph JH; Humphrey SD; Biesman BS; Gallagher CJ; Liu Y; Rubio RG; ;
    Plast Reconstr Surg; 2020 Jan; 145(1):45-58. PubMed ID: 31609882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study.
    Wu Y; Zhao G; Li H; Zheng Z; Zhong S; Yang Z; Feng Z; Yang Q; Zhu X
    Dermatol Surg; 2010; 36(1):102-8. PubMed ID: 20002637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind Trials.
    Guo Y; Lu Y; Liu T; Zhou Y; Yang P; Zhu J; Chen L; Yang Q
    Plast Reconstr Surg; 2015 Sep; 136(3):310e-318e. PubMed ID: 26313835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study.
    Lowe P; Patnaik R; Lowe N
    J Am Acad Dermatol; 2006 Dec; 55(6):975-80. PubMed ID: 17097394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
    Carruthers JA; Lowe NJ; Menter MA; Gibson J; Nordquist M; Mordaunt J; Walker P; Eadie N;
    J Am Acad Dermatol; 2002 Jun; 46(6):840-9. PubMed ID: 12063480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.